• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Maize and Blue Stock Pitch Competition 2024 Showcases Analytical Excellence With Surprising Results, Including A Bearish Call

    2/29/24 5:21:18 PM ET
    $ADEA
    $BUR
    $DLO
    $FL
    Computer Software: Prepackaged Software
    Technology
    Finance: Consumer Services
    Finance
    Get the next $ADEA alert in real time by email

    The Ross School of Business at the University of Michigan hosted the expanded Maize and Blue Stock Pitch Competition on Feb. 9, welcoming an impressive lineup of eight final contestants, an increase from the previous year.

    This competition, sponsored by William Blair & Company, Philadelphia Financial Management of San Francisco and Thrivent Financial, provided a platform for students from diverse academic backgrounds to exercise their stock analysis skills and pitch investment ideas to seasoned professionals.

    While previously restricted to only Maize and Blue Endowment Fund members within the Ross School, the competition expanded to allow students from different disciplines to compete and included non-fund members such as one from the university's College of Literature Science and Arts (LSA) and one from the university's College of Engineering. Six competitors were from the Ross School of Business.

    The competition's updated criteria for 2024 mandated presentations on U.S. publicly traded companies with a market cap of at least $100 million and at least $2 million of daily trading volume from October through December 2023, excluding ADRs, ETFs and other securities.

    The challenge embraced both long and short investment theses, enriching the competition with an array of strategic perspectives. 

    Each contestant showcased exceptional diligence and strategic thinking, offering valuable perspectives on their chosen stocks. (Note: Two names are anonymous per request.)

    See Also: Warren Buffett Ignores Buy-And-Hold Strategy With This Home Builder: Are Other Stocks At Risk?

    First Place: Jayant S. Namdhari - A Persuasive Bear Case on Him & Hers Health

    Jayant S. Namdhari, a sophomore from the Ross School of Business, won first place with an incisive short thesis about Hims & Hers Health Inc. (NYSE:HIMS).

    Namdhari meticulously argued that the market overlooked the company's high-churn business model and limited potential for recurring revenue.  

    Namdhari highlighted the intensifying competition within the sector and the overestimated total addressable market (TAM), which the contestant believed would force the company to revise its long-term targets downward.

    Namdhari's analysis concluded with a price target of $5.98, predicting a significant downside for the company based on these overlooked factors. (Hims & Hers Health closed at $9.85 as of Feb. 8.).

    Second Place: Dylan Castro - Bullish on Garrett Motion's Future

    Securing second place, Castro, a sophomore from the College of Engineering, presented a bullish thesis on Garrett Motion Inc. (NASDAQ:GTX).

    Castro's research focused on the positive impacts of legislative developments on cybersecurity and emissions regulations, which he anticipated would drive significant sales growth over the next five years.

    His analysis praised GTX's superior innovation capabilities and the company's emergence from restructuring, adding a distress premium to the Weighted Average Cost of Capital (WACC) to account for the higher returns demanded by investors. Castro's detailed discounted cash flows (DCF) forecasting supported a price target of $13.35 by December 2025, underscoring his confidence in GTX's growth trajectory. (Garrett Motion closed at $8.28 as of Feb. 8).

    Third Place: Contestant A - Long Thesis on Burford Capital

    Contestant A earned third place with a long thesis on Burford Capital Limited (NYSE:BUR), emphasizing the company's unique position in the market.

    The contestant pointed out how confidentiality, information asymmetry and Burford's established reputation provided a significant first-mover advantage.

    Additionally, the size of its assets limits competition and offers diversification benefits, bolstering the investment case. The analysis highlighted recent settlements in key cases and predicted a price target of $26.70, reflecting the contestant's optimism about Burford's potential for growth. (Burford closed at $14.36 as of Feb. 8).

    Valerie Sherr and Adam Cox Tie for Fourth Place

    Valerie Sherr, a junior from the Ross School of Business, presented a thesis on Adeia Inc. (NASDAQ:ADEA) as an attractive long investment opportunity, focusing on the company's extensive patent portfolio and transition to OTT business.

    Adam Cox, also a junior from the Ross School of Business, showcased a short thesis on Williams-Sonoma, Inc. (NYSE:WSM), detailing the significant headwinds faced by the retailer, including ocean freight challenges and increasing competition, with a price target of $150.

    Honorable Mentions: The competition also awarded several honorable mentions, with each contestant presenting detailed analyses and investment theses on various companies.

    Contestant B's Honorable Mention for a long thesis on Dlocal Ltd (NASDAQ:DLO) highlighted the stock's potential for recovery from a recent short report with a price target of $29.65, citing strong cash flows and a mispriced valuation due to industry misunderstandings.

    Rashmi Nair, a senior studying economics and cognitive science from the College of LSA, issued a short on Foot Locker Inc (NYSE:FL) with a price target of $20.71. Nair critiqued Foot Locker's e-commerce strategy and margin pressures, predicting difficulties in stabilizing market share amidst aggressive competition.

    Vijay Rudraraju, a senior from the Ross School of Business, made a bull case for Gogo Inc (NASDAQ:GOGO), arguing against the overblown concerns of competitive threats, setting a price target of $13.79 and forecasting TAM growth through strategic offerings.

    Looking Ahead: The Maize and Blue Stock Pitch Competition 2024 displayed the analytical prowess and strategic acumen of its participants and set a high standard for future competitions.

    As these aspiring financial analysts move forward, their insights and methodologies will undoubtedly contribute to the evolving landscape of investment analysis.

    Reflecting on the event's success and its contribution to the educational landscape at Michigan, Corey Tobin, partner at William Blair & Company, shared his admiration for the participants' work: "The quality of work at the competition was outstanding, including some of the best ideas and analyses I’ve ever seen at a student event.”

    He added, “Efforts of Professor Pedram Nezafat and the investor mentors are absolutely elevating finance education at Michigan, and preparing students well for entering the industry. I look forward to seeing what next year holds."

    The competition is a testament to the University of Michigan's dedication to fostering a rich educational environment where students can explore and refine their investment strategies, preparing them for successful careers in finance.

    Read Next: Private Equity Bounces Back: EQT Raises $24B For Deals, Signals Listings Revival

    Photo: Shutterstock

    Get the next $ADEA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADEA
    $BUR
    $DLO
    $FL

    CompanyDatePrice TargetRatingAnalyst
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$24.00Sell → Neutral
    Citigroup
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$23.00Underperform → Neutral
    BofA Securities
    Hims & Hers Health Inc.
    $HIMS
    3/9/2026$30.00Hold → Buy
    Needham
    Hims & Hers Health Inc.
    $HIMS
    2/24/2026Buy → Neutral
    BTIG Research
    Burford Capital Limited
    $BUR
    2/20/2026$14.00Outperform
    Wedbush
    Burford Capital Limited
    $BUR
    2/18/2026Buy
    BofA Securities
    Hims & Hers Health Inc.
    $HIMS
    1/12/2026$33.00In-line
    Evercore ISI
    Garrett Motion Inc.
    $GTX
    12/17/2025$23.00Overweight
    Analyst
    More analyst ratings

    $ADEA
    $BUR
    $DLO
    $FL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hims & Hers Names Kathryn Beiser as Chief Communications Officer

    The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world's leading consumer health platform in its next phase of growth Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth. In her role as CCO, Beiser will report to CEO Andrew Dudum and focus on continuing to build the Hims & Hers brand and reputation while helping the industry understand the company's expansive vision for the

    3/10/26 8:08:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

    The program debuts with Prenuvo and Eight Sleep, providing discounts on advanced diagnostics and sleep technology Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced Hims & Hers Benefits, a new way for subscribers to access the best innovations in whole body health. This new initiative provides active subscribers access to discounts from health partners, all in one place, including whole body MRI scans from Prenuvo and adaptive bed systems from Eight Sleep. This is just the beginning of a larger benefits program that will make comprehensive, holistic care more accessible and affordable for subscribers. "True health doesn't happen in a vacuum.

    3/10/26 9:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    WILLIAMS SONOMA AND WILLIAMS SONOMA HOME LAUNCH NEW AERIN COLLECTIONS

    Expansion of Successful Collaborations with AERIN Founder, Aerin Lauder Includes New Assortment of Tabletop, Home Décor and Furniture Williams Sonoma and Williams Sonoma Home, portfolio brands of Williams-Sonoma, Inc. (NYSE:WSM), the world's largest digital-first, design-led and sustainable home retailer, announced today the expansion of the successful collaborations with AERIN, the lifestyle brand founded by Aerin Lauder. The new AERIN for Williams Sonoma and AERIN for Williams Sonoma Home collections blend timeless design with modern functionality and include an assortment of products that draw inspiration from Lauder's East Hampton garden. This press release features multimedia. View

    3/10/26 9:00:00 AM ET
    $WSM
    Home Furnishings
    Consumer Discretionary

    $ADEA
    $BUR
    $DLO
    $FL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & Chief Human Res. Officer Spenninck Fabrice covered exercise/tax liability with 9,214 shares and was granted 17,713 shares, increasing direct ownership by 6% to 159,738 units (SEC Form 4)

    4 - Garrett Motion Inc. (0001735707) (Issuer)

    3/9/26 9:14:34 PM ET
    $GTX
    Auto Parts:O.E.M.
    Consumer Discretionary

    SVP, GC & Corp. Secretary Rollinger Mark D. was granted 23,198 shares, increasing direct ownership by 131% to 40,908 units (SEC Form 4)

    4 - Garrett Motion Inc. (0001735707) (Issuer)

    3/9/26 9:13:00 PM ET
    $GTX
    Auto Parts:O.E.M.
    Consumer Discretionary

    SVP, GM GBEs Turbo Tech Rodrigues Mark Albert covered exercise/tax liability with 4,307 shares and was granted 14,669 shares, increasing direct ownership by 12% to 93,694 units (SEC Form 4)

    4 - Garrett Motion Inc. (0001735707) (Issuer)

    3/9/26 9:10:12 PM ET
    $GTX
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ADEA
    $BUR
    $DLO
    $FL
    SEC Filings

    View All

    Adeia Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Adeia Inc. (0001803696) (Filer)

    3/9/26 8:07:26 AM ET
    $ADEA
    Computer Software: Prepackaged Software
    Technology

    Burford Capital Limited filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Burford Capital Ltd (0001714174) (Filer)

    3/6/26 4:35:01 PM ET
    $BUR
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Hims & Hers Health Inc.

    SCHEDULE 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)

    3/5/26 11:49:35 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $ADEA
    $BUR
    $DLO
    $FL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hims & Hers Health upgraded by Citigroup with a new price target

    Citigroup upgraded Hims & Hers Health from Sell to Neutral and set a new price target of $24.00

    3/10/26 8:37:35 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Health upgraded by BofA Securities with a new price target

    BofA Securities upgraded Hims & Hers Health from Underperform to Neutral and set a new price target of $23.00

    3/10/26 8:37:14 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Health upgraded by Needham with a new price target

    Needham upgraded Hims & Hers Health from Hold to Buy and set a new price target of $30.00

    3/9/26 11:28:34 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $ADEA
    $BUR
    $DLO
    $FL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chair Thorne Oakleigh bought $907,300 worth of shares (170,000 units at $5.34), increasing direct ownership by 22% to 954,098 units (SEC Form 4)

    4 - Gogo Inc. (0001537054) (Issuer)

    12/16/25 4:44:04 PM ET
    $GOGO
    Telecommunications Equipment
    Consumer Discretionary

    Director Townsend Charles C bought $627,527 worth of shares (89,991 units at $6.97) (SEC Form 4)

    4 - Gogo Inc. (0001537054) (Issuer)

    11/20/25 4:01:02 PM ET
    $GOGO
    Telecommunications Equipment
    Consumer Discretionary

    Director Townsend Charles C bought $778,672 worth of shares (110,009 units at $7.08) (SEC Form 4)

    4 - Gogo Inc. (0001537054) (Issuer)

    11/18/25 4:05:07 PM ET
    $GOGO
    Telecommunications Equipment
    Consumer Discretionary

    $ADEA
    $BUR
    $DLO
    $FL
    Leadership Updates

    Live Leadership Updates

    View All

    Hims & Hers Names Kathryn Beiser as Chief Communications Officer

    The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world's leading consumer health platform in its next phase of growth Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth. In her role as CCO, Beiser will report to CEO Andrew Dudum and focus on continuing to build the Hims & Hers brand and reputation while helping the industry understand the company's expansive vision for the

    3/10/26 8:08:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

    Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company's ability to bring access to high-quality, personalized care to more people across the world. As its US business continues to grow, Hims & Hers will be well-positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. The terms of the transaction have been structu

    2/19/26 6:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    WEST ELM LAUNCHES NEW COLLABORATION WITH PINK CHICKEN

    The Collection Brings Pink Chicken's Popular Prints to Modern Home Furnishings Global design company, West Elm, a portfolio brand of Williams-Sonoma, Inc. (NYSE:WSM), the world's largest digital-first, design-led and sustainable home retailer, today announced the launch of a new collaboration with Pink Chicken, the beloved children's clothing brand known for its joyful prints and timeless charm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260202172138/en/Pink Chicken for West Elm Kids (Photo: West Elm) Pink Chicken for West Elm Kids reimagines Pink Chicken's signature prints for kids' spaces. Designed for the spring season

    2/2/26 9:00:00 AM ET
    $WSM
    Home Furnishings
    Consumer Discretionary

    $ADEA
    $BUR
    $DLO
    $FL
    Financials

    Live finance-specific insights

    View All

    $ADEA
    $BUR
    $DLO
    $FL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Gogo Announces Fourth Quarter and Full Year 2025 Results

    Total Q4 Revenue of $230.6 million, up 67% Year-over-Year; Service Revenue of $191.9 million, up 61% Year-over-Year  Full Year Results at High End of 2025 Guidance Range for Revenue, Adjusted EBITDA and Free Cash Flow Gogo Galileo and 5G Expected to Ramp in 2026 Company Provides 2026 Financial Guidance BROOMFIELD, Colo., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (NASDAQ:GOGO) ("Gogo" or the "Company"), a leading global provider of broadband connectivity services for the business and military/government aviation markets, today announced its financial results for the quarter ended December 31, 2025 and full year results for 2025. Fourth quarter and full year 2025 financial results fo

    2/27/26 7:00:00 AM ET
    $GOGO
    Telecommunications Equipment
    Consumer Discretionary

    Burford Reports 4Q25 and FY25 Financial Results

    NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, today announces its financial results for the three months ended December 31, 2025 ("4Q25") and the year ended December 31, 2025 ("FY25"). The full detailed presentation of Burford's 4Q25 and FY25 financial results, as well as a shareholder letter and detailed portfolio data table, can be viewed at http://investors.burfordcapital.com. On February 25, 2026, Burford's board of directors declared a final dividend for the year ended December 31, 2025 of $0.0625 per ordinary share to be paid, subject to shareholder approval at the 2026 annual general me

    2/26/26 8:00:00 AM ET
    $BUR
    Finance: Consumer Services
    Finance

    Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    Revenue of approximately $2.35 billion, up 59% year-over-year in 2025 Net income of $128 million; Adjusted EBITDA of $318 million in 2025 Subscribers grew to over 2.5 million, up 13% year-over-year in 2025 Provides Q1 and full year 2026 guidance1, with full year 2026 revenue in the range of $2.7 billion to $2.9 billion and Adjusted EBITDA in the range of $300 million to $375 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2025 in a shareholder letter that is posted at investors.hims.com. "More than 2.5 million subscribe

    2/23/26 4:05:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Garrett Motion Inc.

    SC 13D/A - Garrett Motion Inc. (0001735707) (Subject)

    12/17/24 4:30:36 PM ET
    $GTX
    Auto Parts:O.E.M.
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Garrett Motion Inc.

    SC 13G/A - Garrett Motion Inc. (0001735707) (Subject)

    11/14/24 4:09:43 PM ET
    $GTX
    Auto Parts:O.E.M.
    Consumer Discretionary

    SEC Form SC 13G filed by Burford Capital Limited

    SC 13G - Burford Capital Ltd (0001714174) (Subject)

    11/14/24 1:24:00 PM ET
    $BUR
    Finance: Consumer Services
    Finance